HomeLIXT • NASDAQ
add
Lixte Biotechnology Holdings Inc
Previous close
$1.44
Day range
$1.36 - $1.52
Year range
$1.02 - $3.49
Market cap
3.70M USD
Avg Volume
12.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 706.94K | -26.88% |
Net income | -709.56K | 26.95% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38M | -59.44% |
Total assets | 1.51M | -57.81% |
Total liabilities | 355.10K | -23.28% |
Total equity | 1.16M | — |
Shares outstanding | 2.68M | — |
Price to book | -1.66 | — |
Return on assets | -132.90% | — |
Return on capital | -177.95% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -709.56K | 26.95% |
Cash from operations | -568.48K | 27.97% |
Cash from investing | — | — |
Cash from financing | 914.23K | — |
Net change in cash | 345.74K | 143.81% |
Free cash flow | -429.96K | -0.77% |
About
Founded
2005
Website
Employees
2
